CD19 and B-cell non-Hodgkin lymphoma: Simonetta et al. reported that 89Zr-desferrioxamine (DFO)-ICOS mAb PET/CT imaging successfully visualized murine CD19.28z CAR-T cells during antitumor responses in B-cell lymphoma [97].